高级检索
当前位置: 首页 > 详情页

Acupuncture for patients with chronic functional constipation: A randomized controlled trial.

文献详情

资源类型:
Pubmed体系:
机构: [1]Chengdu University of Traditional ChineseMedicine, Chengdu, Sichuan, China [2]Guang’anmen Hospital, China Academy ofChinese Medical Sciences, Beijing, China [3]The First Affiliated Hospital of HunanUniversity of Traditional Chinese Medicine,Changsha, Hunan, China [4]Teaching Hospital of Chengdu Universityof Traditional Chinese Medicine, Chengdu,Sichuan, China [5]Institute of Acupuncture andMoxibustion, China Academy of ChineseMedical Sciences, Beijing, China [6]Changchun University of Traditional ChineseMedicine, Changchun, Jilin, China [7]Shanxi University of Traditional ChineseMedicine, Xianyang, Shanxi, China [8]Guangzhou University of Traditional ChineseMedicine, Guangzhou, Guangdong, China [9]Shandong University of Traditional ChineseMedicine, Jinan, Shandong, China [10]Anhui University of Traditional ChineseMedicine, Hefei, Anhui, China
出处:
ISSN:

关键词: acupuncture functional constipation randomized controlled trial

摘要:
Acupuncture is used to treat chronic functional constipation (CFC) in China, despite limited evidence. We aim to assess the effectiveness and safety of acupuncture in managing CFC. A multicenter randomized controlled trial was performed involving 684 patients with CFC; the patients were randomly allocated to receive He acupuncture (n = 172), Shu-mu acupuncture (n = 171), He-shu-mu acupuncture (n = 171), or oral administration of mosapride (n = 170). Sixteen sessions of acupuncture were given in the treatment duration of 4 weeks. The primary outcome was the change in spontaneous bowel movements (SBMs) at week 4 (at the end of treatment) compared to baseline. The secondary outcomes included stool consistency (Bristol scale), the degree of straining during defecation, and adverse events. The SBMs increased in all the four groups at week 4, and the magnitude of increase was equivalent in the four groups (He acupuncture, 2.7 [95% CI, 2.3-3.1]; Shu-mu acupuncture, 2.7 [95% CI, 2.3-3.0]; He-shu-mu acupuncture, 2.2 [95% CI, 1.9-2.5]; and mosapride, 2.4 [95% CI, 2.0-2.9]; P = .226). However, the change in SBMs at week 8 was significantly smaller in mosapride group (1.4 [95% CI, 1.0-1.8]) than the three acupuncture groups (2.4 [95% CI, 2.1-2.7], 2.3 [95% CI, 1.9-2.7], 2.1 [95% CI, 1.7-2.5] in He, Shu-mu, and He-shu-mu group, respectively, P = .005). The three acupuncture treatments were as effective as mosapride in improving stool frequency and stool consistency in CFC, but the magnitude of the treatment effect is unknown due to the lack of sham acupuncture control. © 2018 John Wiley & Sons Ltd.

基金:
语种:
PubmedID:
中科院(CAS)分区:
出版当年[2017]版:
大类 | 2 区 医学
小类 | 2 区 临床神经病学 3 区 胃肠肝病学 3 区 神经科学
最新[2025]版:
大类 | 3 区 医学
小类 | 3 区 临床神经病学 3 区 胃肠肝病学 3 区 神经科学
第一作者:
第一作者机构: [1]Chengdu University of Traditional ChineseMedicine, Chengdu, Sichuan, China
通讯作者:
通讯机构: [2]Guang’anmen Hospital, China Academy ofChinese Medical Sciences, Beijing, China [5]Institute of Acupuncture andMoxibustion, China Academy of ChineseMedical Sciences, Beijing, China [*1]Institute of Acupuncture and Moxibustion, China Academy of Chinese Medical Sciences, Beijing, China. [*2]Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan, China.
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:2022 今日访问量:0 总访问量:648 更新日期:2024-07-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 广东省中医院 技术支持:重庆聚合科技有限公司 地址:广州市越秀区大德路111号